Join John Herr, owner and pharmacist at Town & Country Compounding, as we delve into the crucial topic of obesity and fat shaming highlighted by Oprah Winfrey. In this video, we explore the impact of Oprah’s public struggle with weight and how she has brought much-needed attention to the use of GLP-1 medications like semaglutide and tirzepatide in addressing obesity.
John discusses the biological factors of obesity and the societal impacts of fat shaming, emphasizing the need for a compassionate approach to weight management. Learn how compounded GLP-1 medications are evolving and how compounding pharmacies play a vital role in making these medications more accessible, especially amidst national drug shortages.
Related
